TY - JOUR
T1 - Comparison of oxidant-generation and BP-diol activation by bone marrow cells from C57Bl 6 and DBA 2 mice
T2 - Implications for risk of bone marrow toxicity induced by polycyclic hydrocarbons
AU - Twerdok, Lorraine E.
AU - Mosebrook, D. Randolph
AU - Trush, Michael A.
N1 - Funding Information:
We gratefully acknowledge the financial support for this research by the National Institutes of Health ES 03760, ES 07141, ES 03819, OH 02632, American Cancer Society SIG-3, and a Hazleton Graduate Student Fellowship.
PY - 1992/2
Y1 - 1992/2
N2 - Neutrophil-derived oxidants have been implicated in both the damage to biomolecules and the metabolic activation of xenobiotics. Bone marrow, a relatively neutrophil-rich tissue with low cytochrome P450 activity, is subject to toxicity from orally administered benzo[a]pyrene (BP) in mice with noninducible P450 monooxygenase systems. Thus, we have compared the oxidant generation and chemical activation by neutrophilic cells isolated from femurs of male DBA 2 and C57Bl 6 mice, strains that are susceptible and nonsusceptible, respectively, to bone marrow toxicity from BP. Oxidant generation of neutrophilic preparations was assayed by superoxide anion generation and oxidant-dependent chemiluminescence (CL) from luminol or lucigenin. In all assays, cells from DBA 2 mice demonstrated increased oxidant generation. CL from BP-7,8-dihydrodiol (BP-diol) has previously been shown to correlate with its ability to elicit genotoxic effects. A twofold enhancement of oxidant-dependent CL from BP-diol was observed with TPA-stimulated neutrophilic cells from DBA 2 mice as compared to cells from C57Bl 6 mice. DBA 2-derived bone marrow cells also activated more BP-diol to a DNA covalent binding species than did bone marrow cells derived from the less BP-sensitive C57Bl 6 mouse. Tetraol analysis of BP-diol metabolism by activated bone marrow cells confirmed this greater bioactivation of the diol by DBA 2-derived cells. These results suggest that the increased risk of DBA 2 mice for BP-induced bone marrow toxicity may be related to their greater ability to bioactivate xenobiotics through oxidant-dependent mechanisms.
AB - Neutrophil-derived oxidants have been implicated in both the damage to biomolecules and the metabolic activation of xenobiotics. Bone marrow, a relatively neutrophil-rich tissue with low cytochrome P450 activity, is subject to toxicity from orally administered benzo[a]pyrene (BP) in mice with noninducible P450 monooxygenase systems. Thus, we have compared the oxidant generation and chemical activation by neutrophilic cells isolated from femurs of male DBA 2 and C57Bl 6 mice, strains that are susceptible and nonsusceptible, respectively, to bone marrow toxicity from BP. Oxidant generation of neutrophilic preparations was assayed by superoxide anion generation and oxidant-dependent chemiluminescence (CL) from luminol or lucigenin. In all assays, cells from DBA 2 mice demonstrated increased oxidant generation. CL from BP-7,8-dihydrodiol (BP-diol) has previously been shown to correlate with its ability to elicit genotoxic effects. A twofold enhancement of oxidant-dependent CL from BP-diol was observed with TPA-stimulated neutrophilic cells from DBA 2 mice as compared to cells from C57Bl 6 mice. DBA 2-derived bone marrow cells also activated more BP-diol to a DNA covalent binding species than did bone marrow cells derived from the less BP-sensitive C57Bl 6 mouse. Tetraol analysis of BP-diol metabolism by activated bone marrow cells confirmed this greater bioactivation of the diol by DBA 2-derived cells. These results suggest that the increased risk of DBA 2 mice for BP-induced bone marrow toxicity may be related to their greater ability to bioactivate xenobiotics through oxidant-dependent mechanisms.
UR - http://www.scopus.com/inward/record.url?scp=0026546585&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026546585&partnerID=8YFLogxK
U2 - 10.1016/0041-008X(92)90196-Y
DO - 10.1016/0041-008X(92)90196-Y
M3 - Article
C2 - 1311465
AN - SCOPUS:0026546585
SN - 0041-008X
VL - 112
SP - 266
EP - 272
JO - Toxicology and Applied Pharmacology
JF - Toxicology and Applied Pharmacology
IS - 2
ER -